Differences in myocardial PTEN expression and Akt signalling in type 2 diabetic and nondiabetic patients undergoing coronary bypass surgery

Clinical Endocrinology

Volumn 74, Issue 6, 2011, Pages 705-713

  Wang, Baohua ^a   Raedschelders, Koen ^a   Shravah, Jayant ^a   Hui, Yu ^a   Safaei, Hajieh G ^a   Chen, David D Y ^a   Cook, Richard C ^a   Fradet, Guy ^a   Au, Calvin L ^a   Ansley, David M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLIBENCLAMIDE; GLICLAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ISOPROSTANE DERIVATIVE; METFORMIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE B; ROSIGLITAZONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY SINUS BLOOD FLOW; DRUG USE; ENZYME PHOSPHORYLATION; FEMALE; GLYCEMIC CONTROL; HEART MUSCLE BIOPSY; HEART RIGHT ATRIUM; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARDIOVASCULAR DISEASES; CHROMATOGRAPHY, LIQUID; CORONARY ARTERY BYPASS; CORONARY SINUS; DIABETES MELLITUS, TYPE 2; DINOPROST; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 79955869166     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.03979.x     Document Type: Article

References (35)

1. Brown, J.R., Edwards, F.H., O'Connor, G.T., et al. (2006) The diabetic disadvantage: historical outcomes measures in diabetic patients undergoing cardiac surgery-the pre-intravenous insulin era. Seminars in Thoracic and Cardiovascular Surgery, 18, 281-288. (Pubitemid 46464508)
2. Scrutinio, D., &, Giannuzzi, P., (2008) Comorbidity in patients undergoing coronary artery bypass graft surgery: impact on outcome and implications for cardiac rehabilitation. European Journal of Cardiovascular Prevention and Rehabilitation, 15, 379-385.
3. Leavitt, B.J., (2007) The effects of diabetes mellitus on coronary artery bypass graft surgery. Current Diabetes Reports, 7, 20-24. (Pubitemid 46344185)
4. Ansley, D.M., Raedschelders, K., Chen, D.D.Y., et al. (2009) Rationale, design and baseline characteristics of the PRO-TECT II study: PROpofol CardioproTECTion for Type II diabetics: a randomized, controlled trial of high-dose propofol versus isoflurane preconditioning in patients undergoing on-pump coronary artery bypass graft surgery. Contemporary Clinical Trials, 30, 380-385.
5. Huffmyer, J., &, Raphael, J., (2009) Physiology and pharmacology of myocardial preconditioning and postconditioning. Seminars in Cardiothoracic and Vascular Anesthesia, 13, 5-18.
6. Kehl, F., Krolikowski, J.G., Mraovic, B., et al. (2002) Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology, 96, 183-188. (Pubitemid 34032499)
7. Halkos, M.E., Puskas, J.D., Lattouf, O.M., et al. (2008) Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. Journal of Thoracic and Cardiovascular Surgery, 136, 631-640.
8. Nesto, R.W., &, Lago, R.M., (2008) Glucose: a biomarker in acute myocardial infarction ready for prime time? Circulation, 117, 990-992.
9. Duncan, A.E., Abd-Elsayed, A., Maheshwari, A., et al. (2010) Role of intraoperative and postoperative blood glucose concentrations in predicting outcomes after cardiac surgery. Anesthesiology, 112, 860-871.
10. Hausenloy, D.J., &, Yellon, D.M., (2007) Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Failure Reviews, 12, 217-234. (Pubitemid 350176695)
11. Mullonkal, C.J., &, Toledo-Pereyra, L.H., (2007) Akt in ischemia and reperfusion. Journal of Investigative Surgery, 20, 195-203. (Pubitemid 47050383)
12. Tsang, A., Hausenloy, D.J., Mocanu, M.M., et al. (2005) Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes, 54, 2360-2364. (Pubitemid 41134263)
13. Sivaraman, V., Hausenloy, D.J., Wynne, A.M., et al. (2010) Preconditioning the diabetic human myocardium. Journal of Cellular and Molecular Medicine, 14, 1740-1746.
14. Kang, K.H., Lemke, G., &, Kim, J.W., (2009) The PI3K-PTEN tug-of-war, oxidative stress and retinal degeneration. Trends in Molecular Medicine, 15, 191-198.
15. Song, P., Wu, Y., Xu, J., et al. (2007) Reactive nitrogen species induced by hyperglycemia suppresses Akt signaling and triggers apoptosis by upregulating phosphatase PTEN (phosphatase and tensin homologue deleted on chromosome 10) in an LKB1-dependent manner. Circulation, 116, 1585-1595. (Pubitemid 47511422)
16. Seo, J.H., Ahn, Y., Lee, S.-R., et al. (2005) The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. Molecular Biology of the Cell, 16, 348-357. (Pubitemid 40024316)
17. Sircar, D., &, Subbaiah, P.V., (2007) Isoprostane measurement in plasma and urine by liquid chromatography-mass spectrometry with one-step sample preparation. Clinical Chemistry, 53, 251-258. (Pubitemid 46338269)
18. Gross, E.R., Hsu, A.K., &, Gross, G.J., (2007) Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes, 56, 127-136.
19. Kaviarasan, S., Muniandy, S., Qvist, R., et al. (2009) F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review. Journal of Clinical Biochemistry and Nutrition, 45, 1-8.
20. Faure, P., Polge, C., Monneret, D., et al. (2008) Plasma 15-F2t isoprostane concentrations are increased during acute fructose loading in type 2 diabetes. Diabetes Metabolism, 34, 148-154.
21. Sampson, M.J., Gopaul, N., Davies, I.R., et al. (2002) Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care, 25, 537-541. (Pubitemid 41103349)
22. Monnier, L., Mas, E., Ginet, C., et al. (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295, 1681-1687.
23. Mocanu, M.M., Field, D.C., &, Yellon, D.M., (2006) A potential role for PTEN in the diabetic heart. Cardiovascular drugs and therapy/sponsored by the International Society of Cardiovascular Pharmacotherapy, 20, 319-321. (Pubitemid 44701164)
24. Ruan, H., Li, J., Ren, S., et al. (2009) Inducible and cardiac specific PTEN inactivation protects ischemia/reperfusion injury. Journal of Molecular and Cellular Cardiology, 46, 193-200.
25. Huisamen, B., (2003) Protein kinase B in the diabetic heart. Molecular and Cellular Biochemistry, 249, 31-38. (Pubitemid 37021026)
26. Sasso, F.C., Torella, D., Carbonara, O., et al. (2005) Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. Journal of the American College of Cardiology, 46, 827-834. (Pubitemid 41224806)
27. Wang, B., Shravah, J., Luo, H., et al. (2009) Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochemical and Biophysical Research Communications, 389, 105-111.
28. Pugazhenthi, S., Nesterova, A., Sable, C., et al. (2000) Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. Journal of Biological Chemistry, 275, 10761-10766. (Pubitemid 30212704)
29. Giannini, S., Serio, M., &, Galli, A., (2004) Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity. Journal of Endocrinological Investigation, 27, 982-991. (Pubitemid 40124199)
30. Calvert, J.W., Gundewar, S., Jha, S., et al. (2008) Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling. Diabetes, 57, 696-705.
31. Hasnan, J., Yusof, M.I., Damitri, T.D., et al. (2010) Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Medical Journal, 51, 50-55.
32. Valen, G., Paulsson, G., Bennet, A.M., et al. (2000) Gene expression of inflammatory mediators in different chambers of the human heart. Annals of Thoracic Surgery, 70, 562-567.
33. Butler, M., McKay, R.A., Popoff, I.J., et al. (2002) Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes, 51, 1028-1034. (Pubitemid 34438346)
34. Cai, Z., &, Semenza, G.L., (2005) PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circulation Research, 97, 1351-1359.
35. Matsui, T., &, Rosenzweig, A., (2005) Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt. Journal of Molecular and Cellular Cardiology, 38, 63-71. (Pubitemid 40038652)